Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.
- Published In:
- Neuroscience and behavioral physiology, 52(6), 836-841 (2022)
- Authors:
- Putilina, M V, Mutovina, Z Yu, Kurushina, O V, Khalilova, D M, Saverskaya, E N, Stepanova, S B, Khoreva, M A, Starikov, A S
- Database ID:
- RPEP-06438
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06438APA
Putilina, M V; Mutovina, Z Yu; Kurushina, O V; Khalilova, D M; Saverskaya, E N; Stepanova, S B; Khoreva, M A; Starikov, A S. (2022). Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.. Neuroscience and behavioral physiology, 52(6), 836-841. https://doi.org/10.1007/s11055-022-01307-2
MLA
Putilina, M V, et al. "Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.." Neuroscience and behavioral physiology, 2022. https://doi.org/10.1007/s11055-022-01307-2
RethinkPeptides
RethinkPeptides Research Database. "Determination of the Prevalence of Postcovid Syndrome and As..." RPEP-06438. Retrieved from https://rethinkpeptides.com/research/putilina-2022-determination-of-the-prevalence
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.